Article 1 of 3
Kathleen is 46 years old, lives outside Medford, and has a life that runs on competence. She manages a small business, raises two teenagers, and until about three years ago, never thought much about her health. She was the person who showed up. Who followed through. Who got things done.
Then, gradually, she wasn’t.
It didn’t happen all at once. It started as fatigue — the kind that sleep doesn’t fix. Then brain fog, a cotton-wool feeling that made her second-guess conversations she’d had a hundred times before. Her digestion slowed. Her joints ached. She gained weight despite eating carefully. Her periods became erratic. She started canceling things. Then she started canceling herself — the version of herself she recognized.
Her primary care doctor, a thoughtful and genuinely caring physician stretched thin across a full panel of patients, ran a blood test. The result came back with a mildly elevated TSH — thyroid stimulating hormone — and a free T4 that sat at the low end of normal. The doctor recognized the pattern, explained that Kathleen’s thyroid wasn’t performing optimally, and started her on Armour Thyroid, a desiccated thyroid extract that contains both T4 and T3 hormones. It was a reasonable call. A caring call.
Six months later, not much had changed.
The labs, run again, looked acceptable. TSH had come down. Free T4 was in range. On paper, Kathleen was treated. In her body, she was still disappearing.
Over the next two years, Kathleen’s symptoms compounded. Chronic pain moved into her life like an uninvited tenant. Constipation became a daily battle. Her mood darkened. She was referred to an endocrinologist — the specialist, the expert — who ran the standard panel, found numbers that fell within reference ranges, and increased her dose. Kathleen left the office with a higher prescription and the unspoken message that the problem might not be her thyroid after all. Maybe it was depression. Maybe it was stress. Maybe, at 46, this was just what getting older felt like.
It wasn’t.
Kathleen’s story is not rare in Southern Oregon. It plays out in clinics across Medford, Ashland, Grants Pass, and Klamath Falls every single week. And understanding why — understanding the specific scientific, structural, and systemic reasons why a well-meaning medical system keeps failing patients like Kathleen — requires going back to biology. Not the biology you learned in a high school health class. The real biology. The kind that, when you understand it, makes the inadequacy of standard thyroid care feel not just frustrating, but almost inevitable.
A Gland With a Secret Life
There is a small, butterfly-shaped gland sitting at the base of your throat, just below your Adam’s apple, that most people never think about until something goes wrong. The thyroid gland weighs less than an ounce. It is, in the hierarchy of organs, easy to overlook. And yet its hormones reach into virtually every cell in your body — influencing how fast your heart beats, how efficiently your mitochondria burn fuel, how clearly your brain thinks, how well your gut moves, how warm you feel, how heavy your bones become, how your mood is regulated, and how quickly you age.
To understand what goes wrong in thyroid disease, you have to understand what goes right — and the story of what goes right is considerably more complicated than most physicians are taught, and far more complicated than most patients are ever told.
The thyroid gland has one unusual and defining obsession: iodine. It pulls iodine from your bloodstream — iodine that you absorb from food, primarily seafood, dairy, and iodized salt — and uses it as the essential raw material for making thyroid hormone. Without iodine, the whole system collapses. This is why iodine deficiency was, for most of human history, one of the leading causes of developmental disability worldwide, and why the decision to add iodine to table salt in the 1920s ranks among the most consequential public health interventions ever undertaken.
The thyroid takes that iodine and builds it into a molecule called T4 — so named because it carries four iodine atoms. T4 is stored in vast quantities within the thyroid itself, held in a kind of biological warehouse, waiting to be released into the bloodstream on demand. And here is where most explanations of thyroid function stop, and where the real story begins.
T4, by itself, does almost nothing.
The Inactive Hormone and the Enzyme That Wakes It Up
Think of T4 as a key that hasn’t been cut yet. It has the right general shape, but it won’t open any locks. It circulates through your bloodstream — bound mostly to carrier proteins, hitchhiking through your body — in a kind of dormant state. The cells and tissues of your body are studded with thyroid hormone receptors, and those receptors are famously unimpressed by T4. They have very low affinity for it. T4 knocks on the door, and the door doesn’t open.
For the door to open, something has to happen to T4 first. One of its four iodine atoms has to be removed.
When that single iodine atom is stripped away — by a family of enzymes called deiodinases — T4 becomes T3, triiodothyronine. And T3 is an entirely different molecule in terms of biological power. T3 binds to thyroid receptors with high affinity. It fits the lock perfectly. Once inside the cell, T3 travels to the nucleus, where it latches onto DNA and begins regulating gene expression — turning certain genes on, others off, reshaping how the cell behaves at the most fundamental level. Every cell in your body that has a thyroid receptor is listening for T3. And the consequences of that conversation touch everything: metabolism, heat production, heart rate, mood, cognition, digestion, immune function, fertility, and more.
This is why the story of thyroid hormone is not really the story of a gland. It is the story of a conversion process — a dynamic, tissue-level, constantly-adjusting system of activation and deactivation that operates largely invisibly, far from any standard blood test.
There is a beautiful evolutionary logic to this arrangement. The body needs to preserve iodine. By storing the hormone in its inactive, four-iodine form and only converting it to the active three-iodine form in the tissues where it’s actually needed, the body maintains a massive reserve while minimizing waste. The iodine that gets removed during activation? It gets recycled. The system is elegant, ancient, and remarkably thrifty.
But elegance, as we will see, creates complexity. And complexity creates failure points.
Three Enzymes, Three Roles, One System Nobody Fully Measures
The deiodinase enzymes are at the heart of everything that is misunderstood about thyroid disease. There are three of them, and they have distinct personalities.
Type 1 deiodinase (D1) lives primarily in the liver and kidneys. It is, relatively speaking, a workhorse rather than a thoroughbred — it has modest affinity for T4, and it plays a supporting role in converting T4 to T3. But D1 has a crucial second function: it clears reverse T3 from circulation. And D1 is exquisitely sensitive to insulin and carbohydrate intake. When you fast, when insulin drops, when carbohydrates disappear from your diet, D1 activity falls. This has consequences we’ll return to.
Type 2 deiodinase (D2) is the star of the activation story. It has roughly a thousand times greater affinity for T4 than D1. It is the primary engine of T3 production outside the thyroid — responsible for approximately 80% of the T3 generated in peripheral tissues. D2 is richly expressed in the brain, the pituitary gland, the hypothalamus, and brown adipose tissue. It is the enzyme that allows individual tissues to regulate their own thyroid hormone environment independently of what’s happening in the bloodstream. This is a point of staggering importance that we will unpack shortly.
Type 3 deiodinase (D3) does only one thing: it inactivates thyroid hormone. D3 takes T3 — the fully active, receptor-binding, gene-regulating molecule — and converts it into T2, a biologically dead compound. It also takes T4 and converts it not to T3 but to reverse T3, another inactive molecule. D3 is the body’s off-switch for thyroid activity. It is the mechanism by which tissues protect themselves from too much thyroid hormone stimulation — and the mechanism by which the body can rapidly dial down thyroid activity in response to illness, starvation, or severe stress.
Here is what makes this system so difficult to capture in a blood test: the deiodinases operate at the tissue level. Their activity cannot be measured directly in a blood draw. You would need a tissue biopsy. What the bloodstream shows you is a downstream reflection of what the deiodinases are doing — not the activity itself.
This is not a minor technical footnote. It is the central problem of thyroid diagnosis.
The Local Economy of Thyroid Hormone
To appreciate why this matters clinically, consider what happens in brown adipose tissue — the specialized fat that generates heat to warm the body. Brown fat is packed with Type 2 deiodinase. When an animal emerges from hibernation, or when a person is exposed to cold, the brown fat’s D2 enzymes go into overdrive, converting T4 to T3 locally. Inside the brown fat tissue, T3 levels can increase ten-fold within hours.
Ten-fold. Within hours.
Meanwhile, in the bloodstream? Nothing. The circulating levels of thyroid hormone don’t budge. If you drew blood from that animal or that person during this process, you would see perfectly normal thyroid labs. You would conclude, based on the blood test, that nothing was happening with thyroid hormone.
But in the tissue, everything was happening. The local surge in T3 was driving the brown fat’s mitochondria to generate heat — the biological furnace firing up exactly when and where it was needed. When researchers knocked out the D2 enzyme in brown fat, the heat production dropped dramatically. The blood levels of thyroid hormone were irrelevant. What mattered was what was happening in the tissue.
The same principle applies to the brain. Most of the T3 that acts on your neurons does not come directly from your bloodstream. It is produced locally, within the brain, by D2 enzymes converting T4 to T3 in situ. The blood-brain barrier is not the only gatekeeper here — the deiodinase system creates an entirely separate, tissue-specific economy of thyroid hormone activity that runs in parallel to, and largely independent of, what circulates in your blood.
This is why Antonio Bianco, one of the world’s leading thyroid physiologists and the author of Rethinking Hypothyroidism, spent decades in the laboratory studying deiodinases before it finally changed how he practiced medicine. He had been telling patients that T3 levels didn’t matter, that TSH and free T4 were sufficient, that the standard approach was adequate — not out of negligence, but because that was what the field taught. The tissue-level biology was his research world. The clinic was a different world. It took two patients — both teachers, both women, both of whom lost careers they loved because hypothyroidism had taken their cognition — to force those two worlds into collision.
The Thermostat and the Room Temperature
Before we go further, we need to understand the control system that sits above all of this — the feedback loop that generates the one number most doctors use to assess thyroid function: TSH.
The hypothalamus is a small region of the brain that serves as the body’s master regulator of several hormonal systems. It sits, crucially, at the edge of the blood-brain barrier — positioned to sense what is circulating in the bloodstream. The hypothalamus monitors thyroid hormone levels the way a thermostat monitors room temperature. When levels are too low, it sends a signal. When levels are sufficient, it quiets down.
That signal takes the form of TRH — thyrotropin releasing hormone — which travels to the pituitary gland. The pituitary, in response, releases TSH — thyroid stimulating hormone — into the bloodstream. TSH travels to the thyroid gland and tells it to produce more T4. As T4 levels rise, the hypothalamus senses this (through local D2 conversion of T4 to T3), dials back TRH, the pituitary dials back TSH, and the thyroid eases off production. It is a beautifully self-regulating loop.
TSH, then, is not a direct measure of thyroid hormone. It is a measure of the pituitary’s response to thyroid hormone levels. It is one step removed from the thing we actually care about — and it is several steps removed from what is happening in the tissues.
Think of TSH as the thermostat reading, not the room temperature. The thermostat can tell you that the heating system is trying hard (high TSH) or coasting (low TSH). But it cannot tell you whether the radiator in the bedroom is actually warm. It cannot tell you whether the heat is reaching the far corners of the house. It cannot tell you whether the insulation in the walls is working or failing.
For most people, most of the time, the thermostat reading is a useful proxy. If TSH is dramatically elevated, the thyroid is almost certainly underperforming. If TSH is suppressed to near zero, the thyroid is almost certainly overperforming or the person is taking too much thyroid medication. The thermostat is not useless.
But for a significant subset of patients — and current estimates suggest this may be 10 to 20 percent of people treated for hypothyroidism — the thermostat reading can look perfectly normal while the rooms are cold. The central feedback loop is satisfied while the peripheral tissues remain undertreated. TSH normalizes. Symptoms persist. The doctor sees a normal lab and looks for another explanation. The patient is left wondering if the problem is in their head.
When the Body Pumps the Brakes
To understand how the system can look normal while being inadequate, consider what happens during a prolonged fast — a scenario that illuminates the deiodinase system in stark relief.
When you stop eating, your insulin levels fall. Your leptin — a hormone produced by fat cells that signals energy abundance — begins to drop. The hypothalamus reads these signals as evidence of scarcity. And in response, it does something that made perfect evolutionary sense for most of human history: it tells the system to slow down.
Thyroid hormone accelerates energy expenditure. T3 drives your mitochondria to burn fuel, generate heat, and power every energy-consuming process in your body. In a period of food scarcity, running the engine at full throttle is a liability. So the hypothalamus begins to suppress the system — not dramatically enough to show up as frank hypothyroidism, but enough to reduce metabolic rate and conserve energy.
Here is how it happens. TSH may rise slightly, but not as much as you’d expect given falling T4 — because the hypothalamus is actively suppressing the normal compensatory response. More importantly, the deiodinase balance shifts. D1 activity in the liver falls as insulin drops. D3 activity increases. The conversion of T4 to T3 decreases. The conversion of T4 to reverse T3 — the inactive decoy molecule — increases. Reverse T3 rises in the bloodstream, partly because more is being made, and partly because the D1 enzyme that normally clears it is suppressed.
The net effect: less active T3 reaching the tissues, more inactive reverse T3 occupying the space, and a metabolic rate that has quietly, measurably declined. The person feels colder. More fatigued. Mentally slower. Weight loss plateaus despite continued food restriction.
Now consider what this same dynamic looks like in a patient with chronic illness, or unrelenting psychological stress, or inflammatory conditions like autoimmune disease — all of which can drive similar shifts in the deiodinase balance. The TSH may be normal. The free T4 may be normal. But the ratio of active T3 to inactive reverse T3 may be telling an entirely different story — one that standard labs don’t capture.
This is the story that Kathleen’s labs were not telling.
Hashimoto’s: When the Body Attacks Itself
In Kathleen’s case, as in the majority of hypothyroidism cases in the United States, the underlying cause is an autoimmune condition called Hashimoto’s thyroiditis. The immune system — for reasons that remain incompletely understood — fails to recognize the thyroid as self. It produces antibodies, primarily against an enzyme called thyroid peroxidase (TPO), that mark the thyroid gland for destruction. Immune cells infiltrate the gland. Over months and years, the thyroid is slowly dismantled.
The early stages of this process are insidious. The thyroid, being a resilient organ with substantial reserve capacity, can compensate for significant damage before blood tests register anything obviously wrong. TSH begins to creep up. Free T4 remains in range. The patient feels unwell. The labs look acceptable. This phase — called subclinical hypothyroidism — can persist for years before crossing into overt hypothyroidism.
But here is the detail that most clinical discussions of Hashimoto’s omit: the antibodies themselves may not confine their destruction to the thyroid.
Research has shown that women with positive TPO antibodies — even those with perfectly normal thyroid function — have significantly higher rates of miscarriage and preterm birth. Not because their thyroid hormone is low. Because the same immune dysregulation that is attacking the thyroid appears to be active elsewhere in the body. Approximately 30% of patients with positive TPO antibodies also carry antibodies against brain tissue or other organs. Hashimoto’s is not simply a thyroid disease. It is a thyroid-focused manifestation of a broader autoimmune process — and treating only the downstream hormonal deficiency while ignoring the upstream immune dysregulation is, to use a medical metaphor, like mopping the floor while the faucet is still running.
The standard of care does not address the autoimmunity. It replaces the hormone and waits for the gland to finish dying. There are emerging data suggesting that selenium supplementation, vitamin D optimization, and reduction of inflammatory burden can slow the autoimmune destruction and extend what researchers call the “honeymoon period” — the window during which the thyroid retains some functional capacity. These interventions are not yet standard of care, but they are scientifically grounded, low-risk, and increasingly practiced by physicians who have looked carefully at the evidence. This is precisely the kind of gap where integrative and functional medicine approaches, when applied rigorously and in coordination with conventional care, have genuine value to offer.
The Structural Failure: What Southern Oregon Patients Are Up Against
Kathleen lives in a region that, like much of rural America, faces a quiet but consequential shortage of endocrinological expertise. There are a limited number of endocrinologists practicing in the Medford-Grants Pass corridor, and their wait times reflect the mismatch between supply and demand. For a patient with complex, incompletely-treated thyroid disease, getting to a specialist can mean waiting months — and then, as Kathleen discovered, the specialist may be operating from the same incomplete framework as the primary care physician.
This is not a criticism of individual physicians. The PCPs of Southern Oregon are, by and large, doing their best with the training they received and the time they have. The problem is structural and educational. Medical school training in thyroid physiology tends to be abbreviated. The deiodinase system — the tissue-level conversion machinery that is central to understanding why standard treatment fails a meaningful minority of patients — receives little attention in clinical training. The nuances of free T3 measurement, the significance of reverse T3, the limitations of relying solely on TSH as a treatment target: these are not part of the standard curriculum. They are the province of research scientists, not clinicians.
Into this gap, functional medicine has moved — with variable results. At its best, functional medicine in Southern Oregon is providing patients like Kathleen with a more comprehensive evaluation, a longer appointment, and a willingness to look beyond TSH and free T4. At its worst, it is offering expensive, poorly-evidenced panels and treatments to patients who are desperate and therefore vulnerable. The challenge for the region’s healthcare ecosystem is to integrate the legitimate insights of functional medicine — the attention to root cause, the comprehensive biomarker assessment, the lifestyle and nutritional interventions — into a conventional framework that provides the guardrails of evidence-based medicine.
This is the gap that Reimagine Healthcare exists to address.
What Kathleen Didn’t Know She Needed to Ask
When Kathleen left her endocrinologist’s office with an increased dose of Armour Thyroid and a vague sense of having been dismissed, she didn’t yet have the language to articulate what was missing. She didn’t know that her free T3 had never been measured with a precision assay. She didn’t know that reverse T3 — the inactive decoy that competes with active hormone for receptor binding — had never been checked. She didn’t know that her TPO antibodies, though detected, had never been discussed as evidence of a broader immune process that might be addressable. She didn’t know that the ratio of her active to inactive thyroid hormone might be telling a story that her TSH could never tell.
She didn’t know, in other words, that the map her doctors were using was missing most of the terrain.
In the next article in this series, we will look specifically at what a comprehensive thyroid evaluation actually requires — what labs should be run, why the standard panel is insufficient for a significant portion of patients, what the evidence says about measuring free T3 with precision assays, and what the ratio of free T3 to reverse T3 reveals that TSH cannot. We will give both patients and primary care physicians in Southern Oregon a concrete, evidence-based roadmap for what good diagnostic practice looks like.
Because Kathleen’s story doesn’t end in that endocrinologist’s office. It continues — and it gets better. But only after she learns enough to ask the right questions.
Key Takeaways from Article 1
- The thyroid produces mostly T4, an inactive prohormone. The active hormone, T3, is produced primarily in peripheral tissues by enzymes called deiodinases — not by the thyroid itself.
- Deiodinase activity cannot be measured directly in a blood test. It operates at the tissue level, creating a local economy of thyroid hormone that can diverge significantly from what circulating blood tests show.
- TSH is a useful but incomplete proxy for thyroid function. It reflects the pituitary’s response to circulating hormone levels — not what is happening in individual tissues.
- The balance between T3 (active) and reverse T3 (inactive) reflects deiodinase activity and can reveal metabolic suppression that TSH entirely misses.
- Hashimoto’s thyroiditis, the most common cause of hypothyroidism, is a systemic autoimmune condition — not simply a thyroid problem. Standard treatment addresses only the hormonal deficiency, not the underlying immune dysregulation.
- Southern Oregon faces a structural shortage of endocrinological expertise and a gap in PCP training on thyroid complexity — a gap that functional medicine is partially filling, with mixed results.
Next: Article 2 — “Normal Is Not Optimal: The Lab Testing Gap and What Your Thyroid Panel Is Missing”
Editorial Disclaimer
This article is investigative health journalism produced by Reimagine Healthcare, a Southern Oregon initiative dedicated to closing the gap between emerging medical evidence and everyday clinical practice. It is not medical advice, does not constitute a clinical recommendation, and is not a substitute for the individualized care of a licensed healthcare provider. The information presented here is drawn from peer-reviewed research, published scientific literature, and the work of recognized experts in thyroid physiology. Readers are encouraged to use this material to inform conversations with their own physicians — not to replace them. If you have concerns about your thyroid health, please consult a qualified medical professional. Reimagine Healthcare does not endorse any specific laboratory, pharmacy, supplement, or treatment protocol.